Mergers & Acquisitions

  • December 17, 2025

    Warner Bros. Board Rejects 'Inferior' Paramount Bid

    Warner Bros. Discovery Inc. said Wednesday that its board has determined Paramount Skydance Corp.'s $108.4 billion hostile offer is not a "superior proposal" to the company's pending $82.7 billion agreement with Netflix. 

  • December 17, 2025

    Finance Co. Gets Extra Time To Make £523M UK Credit Biz Bid

    Britain's merger regulator has extended the deadline of U.S. finance group BasePoint Capital LLC to table a £523 million ($697 million) bid for International Personal Finance PLC, the U.K. credit provider said Wednesday.

  • December 17, 2025

    Greencore's £1.2B Bakkavor Deal To Complete After CMA OK

    Irish food manufacturer Greencore said Wednesday that it expects its £1.2 billion ($1.6 billion) acquisition of rival Bakkavor to complete in January after the U.K.'s competition authority abandoned its probe amid antitrust fixes proposed by the sides.

  • December 16, 2025

    Judge Skeptical Of Trump-Tied SPAC's Defense In SEC Suit

    A former Trump business associate appeared unlikely to win early dismissal of a U.S. Securities and Exchange Commission suit accusing him of hiding advanced merger discussions with the president's media company from SPAC investors in 2021, as a federal judge wondered Tuesday how the talks could be considered immaterial.

  • December 16, 2025

    Va. Judge Advances Most Claims In Stelara Antitrust Case

    A Virginia federal judge has allowed health insurer CareFirst's anticompetition and patent fraud claims against Johnson & Johnson to move forward in a case alleging anticompetitive behavior in relation to the immunosuppressive drug Stelara, while letting the pharmaceutical giant escape some claims of misrepresentation.

  • December 16, 2025

    The Most Important Healthcare And Life Science Deals Of 2025

    Attorneys taking stock of 2025 spoke to Law360 about the most important deals of the year, including Pfizer’s high-profile acquisition of Metsera and transactions in outpatient services and gene therapy.

  • December 16, 2025

    Trends That Shaped Healthcare Dealmaking In 2025

    With 2025 coming to a close, Law360 Healthcare Authority asked attorneys focused on healthcare deals for their take on the trends that influenced dealmaking over the last 12 months.

  • December 16, 2025

    PE Giant KKR Plugs $220M Into Dubai-Based Premialab

    Data, analytics and risk management solutions provider Premialab, advised by A&O Shearman, on Tuesday revealed that it received a $220 million growth investment from Gibson Dunn & Crutcher LLP-led private equity giant KKR.

  • December 16, 2025

    JP Morgan PE Group's Latest Fund Exceeds Target At $1.44B

    J.P. Morgan Asset Management's private equity group closed its 12th flagship fund, PEG Global Private Equity XII, above its $1.25 billion target at $1.44 billion, the firm announced Tuesday. 

  • December 16, 2025

    Kering, Ardian Form $900M JV At Luxury NYC Property

    French luxury group Kering said Tuesday it has completed another real estate joint venture with private equity firm Ardian, expanding a partnership launched earlier this year with a $900 million deal for a Fifth Avenue retail property in New York City.

  • December 15, 2025

    Del. Justices Put ITG On Hook For $250M Reynolds Settlement

    Delaware's Supreme Court stubbed out an eight-year ITG Brands LLC legal battle to avoid paying R.J. Reynolds more than $250 million to cover health-related settlement payments to Florida after ITG's acquisition of four of the cigarette company's brands, according to a ruling issued Monday.

  • December 15, 2025

    Fast-Track Sale Timeline Denied In Furniture Co. Ch. 11

    A Delaware bankruptcy judge rejected an expedited timeline for the sale of the assets of home furnishing retailer American Signature Furniture, finding that the proposed 34-day process would not give enough time for an investigation of insider claims and the appointment of a consumer privacy ombudsman.

  • December 15, 2025

    Cencora Pays $5B For Majority Stake Of OneOncology

    Pharmaceutical company Cencora Inc. unveiled plans Monday to acquire a majority stake in cancer care company OneOncology for $5 billion, buying interest from private equity shop TPG in a deal built by three law firms.

  • December 15, 2025

    Juventus Rejects Crypto Firm Tether's Bid, Stock Soars

    The owners of Italian football club Juventus rejected an unsolicited buyout bid from crypto firm Tether, saying there is "no intention" of selling shares and helping to push the club's market capitalization above $1 billion as its stock surged Monday.

  • December 15, 2025

    Investment Firms Nab Quipt Home Medical In $260M Deal

    Medical equipment provider Quipt Home Medical Corp. on Monday announced plans to go private after being purchased by a special purpose acquisition vehicle funded by investment firms Kingswood Capital Management and Forager Capital Management in a deal that values the company at $260 million and was built by three law firms.

  • December 15, 2025

    Catching Up With Delaware's Chancery Court

    Litigation in Delaware's Court of Chancery sprawled from a dispute over control of banana plantations along Africa's Congo River to a fight over the late musician Prince's estate last week. Along the way, a court ruling rejected a motion for a quick decision favoring Blue Bell Creameries director and officer calls for liability releases in a tainted ice cream saga that dates to 2015.

  • December 15, 2025

    Europe Seen As Top Tech M&A Prospect For 2026

    Europe has quietly become tech dealmakers' top hunting ground, as global tech mergers and acquisitions values skyrocketed more than 72% in the first three quarters of the year, according to a new global survey from Morrison Foerster LLP.

  • December 15, 2025

    McDermott-Led Sobi To Buy US Gout Specialist For $1.5B

    Swedish biopharma company Swedish Orphan Biovitrum AB said Monday that it has agreed to acquire Arthrosi Therapeutics Inc., a specialist in treatment for gout, for up to $1.5 billion in a deal guided by McDermott.

  • December 12, 2025

    Live Nation Consumers Get Class Certified In Antitrust Case

    A California federal judge Friday certified a class of consumers accusing Live Nation of monopolizing the live entertainment industry, rejecting the company's argument that there aren't common issues that predominate over individual ones and adopting a tentative ruling he issued earlier this month.

  • December 12, 2025

    Printing Co. Defends Trial Win In $265M ESOP Sale Dispute

    A printing company's directors and employee stock ownership plan trustee say the Seventh Circuit should back their win over accusations they illegally undersold the company into private equity for $265 million, arguing the trial court correctly decided their interests were "perfectly aligned" with plan participants' interests.

  • December 12, 2025

    Prospect Medical Wins OK For Chapter 11 Plan

    A Texas bankruptcy judge approved Prospect Medical Holdings Inc.'s Chapter 11 plan after overruling a slew of objections during an all-day hearing Friday and allowing the healthcare group to hand off its remaining hospitals and pursue litigation to repay creditors.

  • December 12, 2025

    Wrong Metric Created $2 Valuation, Chancery Suit Says

    A former equity holder in a nutrition services business has sued in Delaware Chancery Court seeking to unwind what it calls a sham $2 repurchase of its ownership interest and to force payment of a separate $2 million deferred purchase price, arguing that the business disregarded contractually mandated valuation mechanics to engineer a zero-value outcome.

  • December 12, 2025

    2 Firms Guide Stake Deal For Data Center Services Company

    Middle market private equity firm Kohlberg will obtain a majority stake in industrial services company Loenbro LLC in a deal guided by Kirkland & Ellis LLP and Greenberg Traurig LLP, the companies announced.

  • December 12, 2025

    Chancery Lets Nextdoor Argue De-SPAC Suit Filed Too Late

    The Delaware Chancery Court on Friday let Nextdoor Inc. and related defendants argue that investors waited too long to sue over the company's de-SPAC merger, while pausing discovery as the court considers motions that could end the case.

  • December 12, 2025

    MVP: Wachtell Lipton's Jake Kling

    Jake Kling of Wachtell Lipton Rosen & Katz guided Global Payments' $24.25 billion acquisition of Worldpay and the PGA Tour's groundbreaking $3 billion investment from Strategic Sports Group, earning him a spot as one of the 2025 Law360 Mergers & Acquisitions MVPs.

Expert Analysis

  • IP Due Diligence Tips For AI Assets In M&A Transactions

    Author Photo

    Artificial intelligence systems' integration into business operations creates new considerations for intellectual property due diligence in mergers and acquisitions and financing transactions, and implementing a practical approach to identifying AI assets can help avoid litigation and losses, say Armin Ghiam and Senna Hahn at Hunton.

  • AbbVie Frees Taxpayers From M&A Capital Loss Limitations

    Author Photo

    The U.S. Tax Court’s June 17 opinion in AbbVie v. Commissioner, finding that a $1.6 billion break fee was an ordinary and necessary business expense, marks a pivotal rejection of the Internal Revenue Service’s position on the tax treatment of termination fees related to failed mergers or acquisitions, say attorneys at Holland & Knight.

  • Capital One Deal Approval Lights Up Path For Bank M&A

    Author Photo

    The federal banking regulators' recent approval of Capital One's acquisition of Discover signals the agencies' willingness to approve large transactions and a more favorable environment generally for bank mergers under the Trump administration, say attorneys at Arnold & Porter.

  • Series

    Playing The Violin Makes Me A Better Lawyer

    Author Photo

    Playing violin in a string quartet reminds me that flexibility, ambition, strong listening skills, thoughtful leadership and intentional collaboration are all keys to a successful legal practice, says Julie Park at MoFo.

  • DOJ's 1st M&A Declination Shows Value Of Self-Disclosures

    Author Photo

    The U.S. Department of Justice's recent decision not to charge private equity firm White Deer Management — the first such declination under an M&A safe harbor policy announced last year — signals that even in high-priority national security matters, the DOJ looks highly upon voluntary self-disclosures, say attorneys at Perkins Coie.

  • Series

    Law School's Missed Lessons: Practicing Self-Care

    Author Photo

    Law schools don’t teach the mental, physical and emotional health maintenance tools necessary to deal with the profession's many demands, but practicing self-care is an important key to success that can help to improve focus, manage stress and reduce burnout, says Rachel Leonard​​​​​​​ at MG+M.

  • Nev. Steps Up Efforts To Attract Incorporations With New Law

    Author Photo

    Recent amendments to Nevada corporate law, which will narrow controlling stockholders’ liability, streamline mergers and allow companies to opt out of jury trials, show the interstate competition to attract new and reincorporating companies is still heating up, say attorneys at Simpson Thacher.

  • ABA Opinion Makes It A Bit Easier To Drop A 'Hot Potato'

    Author Photo

    The American Bar Association's recent ethics opinion clarifies when attorneys may terminate clients without good cause, though courts may still disqualify a lawyer who drops a client like a hot potato, so sending a closeout letter is always a best practice, say attorneys at Thompson Hine.

  • Plan For Increased HSR Info Sharing With Wash. Antitrust Law

    Author Photo

    Washington's merger notification requirements, effective later this month, combined with the Federal Trade Commission's new Hart-Scott-Rodino Act rules, will result in greater information sharing among state and federal agencies, making it important for merging parties to consider their transaction's potential state antitrust implications early on, say attorneys at McDermott.

  • Dupes Boom Spurs IP Risks, Opportunities For Investors

    Author Photo

    The rising popularity of dupe products has created a dynamic marketplace where both dupes-based businesses and established branded companies can thrive, but investors must consider a host of legal implications, especially when the dupes straddle a fine line between imitation and intellectual property infringement, say attorneys at Ropes & Gray.

  • How Trump's Trade Policies Are Shaping Foreign Investment

    Author Photo

    Five months into the Trump administration, investors are beginning to see the concrete effects of the president’s America First Investment Policy as it presents new opportunities for clearing transactions more quickly, while sustaining risk aversion related to Chinese trade and potentially creating different political risks, say attorneys at Covington.

  • Series

    My Opera And Baseball Careers Make Me A Better Lawyer

    Author Photo

    Though participating in opera and the world of professional baseball often pulls me away from the office, my avocations improve my legal career by helping me perform under scrutiny, prioritize team success, and maintain joy and perspective at work, says Adam Unger at Herrick Feinstein.

  • FTC Focus: Enforcers Study AI Innovation And Entrenchment

    Author Photo

    The Federal Trade Commission and other regulators setting their sights on the burgeoning artificial intelligence ecosystem are considering how the government should approach innovation in tech markets that tend, almost inevitably, toward concentration, say attorneys at Proskauer.

  • 8 Ways Lawyers Can Protect The Rule Of Law In Their Work

    Author Photo

    Whether they are concerned with judicial independence, regulatory predictability or client confidence, lawyers can take specific meaningful actions on their own when traditional structures are too slow or too compromised to respond, says Angeli Patel at the Berkeley Center of Law and Business.

  • Assessing New Changes To Texas Officer Exculpation Law

    Author Photo

    Consistent with Texas' recent modernization of its corporate law, the recently passed S.B. 2411 allows officer exculpation, streamlines certificate of formation amendments, authorizes representatives to act on shareholders' behalf in mergers and makes other changes aimed toward companies seeking a more codified, statutory model of corporate governance, say attorneys at Bracewell.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.